Compare Charlie Hospital Semarang Tbk. (RSCH) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charlie Hospital Semarang Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp268 (market cap 715.5B, 23.56M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 16.3× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (23.56M versus 278.4K). Which is the better fit depends on your goals.
| RSCH | TSPC | |
|---|---|---|
Market Cap | 715.5B | 11.64T |
Volume | 23.56M | 278.4K |
Lot | 235.61K | 2.78K |
Turnover | 6.3B | 723.93M |
Average Price | 267.58 | 2,600.31 |
Value | 6.3B | 723.93M |
Indicative Equilibrium Price | 268 | 2,610 |
Indicative Equilibrium Volume | 70 | 74 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
